10x Genomics CEO Serge Saxonov Sells 30,000 Shares Under 10b5-1 Plan

Serge Saxonov, Chief Executive Officer of 10x Genomics, Inc., sold 30,000 shares of Class A Common Stock on June 22, 2026, through a Rule 10b5-1 trading plan adopted on November 29, 2025. The sales were executed in multiple transactions at weighted average prices ranging from $33.289 to $36.1646 per share, resulting in total proceeds of approximately $1.05 million. Following these transactions, Saxonov's direct ownership decreased to 1,108,380 shares. He also maintains indirect ownership through three trust accounts totaling 285,921 shares. The sales were conducted pursuant to a pre-established trading plan, which allows corporate insiders to sell shares at predetermined times to avoid concerns about trading on material non-public information.